Synthesis and evaluation of MePEG-PCL diblock copolymers: surface properties and controlled release behavior by unknown
ORIGINAL RESEARCH
Synthesis and evaluation of MePEG-PCL diblock copolymers:
surface properties and controlled release behavior
Anjan Kumar Mohanty1 • Utpal Jana1 • Prabal Kumar Manna1 • Guru Prasad Mohanta1
Received: 12 December 2014 / Accepted: 31 July 2015 / Published online: 20 August 2015
 The Author(s) 2015
Abstract The amphiphilic block copolymers are composed
of various combinations of hydrophilic and hydrophobic
block unimers. The variation in unimer ratio alters the surface
aswell asmicelle-forming properties of the block copolymers.
These nanoscopic micelles have the ability to encapsulate
hydrophobic compounds and act as potential drug carrier.
MePEG-PCL copolymers with various block lengths were
synthesized by ring-opening polymerization and character-
ized by 1HNMR, GPC, WXRD and DSC. The number aver-
age molecular weight of the block copolymer was found to
vary from 7511 to 21,270 as determined by GPC and 1HNMR
studies. The surface topology of the polymer films was
determined by AFM analysis, which shows a smoother sur-
face with increasedMePEG contents in the block copolymers.
The protein-binding assay indicates a better biocompatibility
of the block copolymers in comparison to MePEG or PCL
alone. The CMC of the block copolymer provides the infor-
mation about micelle formations for encapsulation of
hydrophobic materials and affects the in vitro release.
Keywords Biodegradable polymers  Drug carrier 
Micelle  CMC  EPR effect
Introduction
Biodegradable block copolymers are well-recognized bio-
materials for their biomedical applications. These copoly-
mers are used for medical devices, along with their
application in carry and release of drugs, peptides or pro-
teins at the characteristic rates and specific target site (Saito
et al. 2001; Uhrich et al. 1999). The block copolymers have
the capability of self assembly into intermittent geometry
with long-range order and contain at least two distinct
polymer chains, covalently bound at one point. The
copolymers have the ability to control their amphiphilic
behavior, mechanical and physical properties by adjusting
the ratio of the constituting blocks or adding new blocks of
desired properties (Leenslag et al. 1987). The brisk
development of block copolymers towards the drug deliv-
ery formulations is due to the versatile and flexible struc-
tural design. On functionalizing both the hydrophilic and
hydrophobic part, the molecular weight of the block
copolymers can be varied within a wide range while
maintaining a constant hydrophilic–lipophilic balance
(HLB). Moreover, the block copolymers are largely used
due to low immunogenicity, biodegradability and bio-
compatibility, which make them suitable for the safe
human administration (Aliabadi and Lavasanifar 2006;
Deming 2000; Mahmud et al. 2007).
The biomaterials such as poly(lactide) (PLA),
poly(lactide-co-glycolide) (PLGA), poly(ethylene glycol)
(PEG) allow the attachment of proteins and peptides by
attaching functional groups into the polymer side chains,
which make them suitable for the cell penetration and
adhesion (Adams et al. 2003; Lavasanifar et al. 2001;
Mohanty et al. 2010). The PEG has the property of
hydrophilicity, nontoxicity and block copolymers consist-
ing of PEG chain can easily form micelles in aqueous
solution at room temperature and this property helps in
drug delivery using the polymers as carrier system. The
sizes of the PEG blocks directly affect the balance of
hydrophobicity and hydrophilicity within a block copoly-
mer which modifies the drug carrying efficacy (Cook et al.
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1997). The polyester, for example, poly(e-caprolactone)
(PCL) exhibits good biodegradability and biocompatibility
and is extensively used for controlled drug delivery and
tissue engineering applications in several formulations. Its
compatibility with a wide range of drugs enables uniform
drug distribution in the formulation matrix and its long-
term degradation facilitates drug release up to several days.
The PCL can be prepared by ring-opening polymerization
of e-caprolactone (CL) activated by catalyst and micro-
initiator. These polymers are used to prepare amphiphilic
block copolymers in aqueous environment with
hydrophobic core by self assembling of lipophilic parts and
vice versa (Jenkins and Harrison 2006; Pulkkinena et al.
2009). These copolymers have the advantage that their
degradation does not result in an acid environment, unlike
the degradation of PLA and PLGA (Kim et al. 2004).
However, due to the high degree of crystallinity and
hydrophobicity, PCL degrades rather slowly and less bio-
compatible with soft tissue, which restricts its further
clinical application. Furthermore, to raise the undesirable
long-term degradation of PCL, modifications in the form of
blend or copolymers are done with other hydrophilic
polymers (Burke et al. 2004).
The common approach to obtain biodegradable poly-
mers that allow surface modification is the copolymeriza-
tion of the PCL with PEG, which improves
biodegradability as compared to the PEG alone The
copolymers also show higher hydrophilicity, mechanical
properties and better performance in the cell culture studies
than the MePEG or PCL homopolymer (Huang et al. 2004;
Moon et al. 2002). The hydrophilic PEG chains control
protein and peptide adsorption and consequently regulate
the behavior of cells to the polymer surface. In addition, the
hydrophobic or hydrophilic core allows repositioning of
encapsulated drug into the core, hence improves the solu-
bility in a monophasic non-solvent medium. Despite many
reports on the synthesis of PEG- and PCL-derived
copolymers (Wang and Qiu 1993; Wang et al. 2013) and
their potential medical and pharmaceutical applications
(Koenig and Huang 1995; Wang et al. 2012), there is little
detailed information available on the bulk microstructure
and surface properties (Zhou et al. 2003; Adams et al.
2003) depending on the copolymer composition. However,
the lipophilic drugs are generally distributed uniformly in
the matrix, while the hydrophilic drugs tend to move
towards the interface and remain on the surface of PEG-
PCL formulation in the adsorbed state (von Burkersroda
et al. 1997). From PEG-PCL-based investigations, it can be
concluded that diffusion is the only possible mechanism by
which the lipophilic drugs release from PEG-PCL formu-
lations as they were reported to be intact for a much longer
duration of in vivo application (Yang et al. 2014; Gou et al.
2009). In case of highly lipophilic drug resisting complete
diffusion, the drugs are released upon surface erosion by
enzymatic action. However, hydrophilic drugs that accu-
mulate at the interface during the formulation processes are
released by desorption at the initial period of release study
or dosage intake. Thus, PEG-PCL block copolymer for-
mulations release the drugs in a biphasic pattern where the
burst release is much higher for hydrophilic drugs than
lipophilic ones (Bazile et al. 1995; Dee et al. 1998; Wang
et al. 2014).
We considered the properties of methoxypoly(ethylene
glycol)-poly(e-caprolactone) diblock copolymers (MePEG-
PCL) in terms of surface topography along with polymer
bulk microstructure to evaluate the contribution of the
MePEG as well as the PCL part to the overall properties of
the block copolymer. The model protein belonging to cell-
penetrating peptides (amino acid composition) category
was chosen, to check the covalent attachment of copolymer
to cell proteins. The hydrolytic degradation and drug
release results are intended to contribute to a better
understanding of the surface properties of these promising
biomaterials and may lead to their efficient use as drug and
cell carriers in future applications.
Materials and methods
Materials
Methoxypoly (ethylene glycol) (MePEG, Mn = 5000 by
supplier, Mn = 5244 by our GPC measurements) was
supplied by Fluka (Sigma-Aldrich, St. Louis, MO), and
purified by azeotropic distillation with dry toluene (Ran-
baxy Fine Chem., India), and dried to constant weight
under vacuum at 30 C before use. e-caprolactone (e-CL)
(Mw = 114.14) was purchased from Fluka and was dried
over calcium hydride for 48 h at room temperature and
then distilled under reduced pressure prior to polymeriza-
tion. Stannous-II octoate (Sn(Oct)2), Pyrene, Trypsin from
bovine pancreas, Na-benzoyl-L-arginine ethyl ester
hydrochloride (BAEE), trypsin inhibitor from soybean,
Tris(hydroxymethyl)-amino methane (TRIS) was obtained
from Sigma-Aldrich Co. (Saint Louis, MO). Distilled-
deionized water was prepared with Milli-Q plus System
(Elix 10, Millipore Corp. India). All other chemicals used
were of reagent grade and used as purchased without fur-
ther purification.
Polymer synthesis
MePEG (molecular weight, 5000 Da) was subjected to
azeotropic distillation with toluene for 6 h to remove the
entrapped moisture and excess toluene was removed by
rotavapor. e-CL was activated by keeping it in activated
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molecular sieves for 24 h. MePEG-PCL diblock copoly-
mers were synthesized by a ring-opening polymerization of
e-CL using MePEG homopolymer as micro-initiator and
Sn(Oct)2 as catalyst. Briefly, 5 mg of different ratios of
MePEG and e-CL was mixed in a 10-ml round bottom flask
connected to vacuum. The mixture was degassed with
vacuum pump (0.28 mbar) and kept at 160 C. When the
polymerization was completed, the reaction product was
cooled at an ambient temperature, and precipitated. The
precipitate was collected by filtration and washed several
times with diethyl ether to remove any residual caprolac-
tone unimers. The resulting product was dried in a vacuum
oven at 40 C for 3 days (Zhou et al. 2003). All block
copolymers (MePEG20-PCL80, MePEG40-PCL60,
MePEG60-PCL40, MePEG80-PCL20) with different
MePEG and PCL ratios were synthesized by adopting the
above method by keeping the final weight of the mixture
constant at 5 mg.
Determination of polymer molecular weight by GPC
The molecular weight and molecular weight distribution
were determined by gel permeation chromatography (GPC).
The chromatography was carried out at 35 C temperature
using HPLC system (Shimadzu Deutschland GmbH, Duis-
burg, Germany) fitted with LC-10AD HPLC pump and
RID-6A refractive index detector coupled with a styragel
HR4 column in an isocratic mode with the deaerated
chloroform as mobile phase at a flow rate of 1 ml/min. The
samples were prepared by dissolving 10 mg of polymer in
2 ml chloroform and filtered through 0.2 lm membrane
filter (Millipore). 50 ll of the sample was injected and
analyzed using ‘‘GPC for Class-Vp’’ software (Shimadzu
Deutschland GmbH, Duisburg, Germany). The molecular
weights were calculated from the elution volume of poly-
styrene standards with molecular weight range of
5610–275,000 Da (Polysciences Asia Pacific, Inc. Taiwan).
1H-NMR spectra
10–20 mg of each sample of copolymers was dissolved in
CDCl3 and
1H-NMR spectra were taken at 300 MHz using
Bruker (Avance, DPX 300, Germany). TMS contained in
CDCl3 served as shift reference. The number average
molecular weight of copolymer and PEG to PCL ratio was
determined by integrating the signal pertaining to each
molecule of the sample.
Analysis of polymer bulk microstructure
with WAXD
The wide-angle X-ray diffraction (WAXD) studies were
carried out to know the crystallographic state of different
MePEG-PCL diblock copolymers. The XRD patterns of
the samples were obtained using XRD diffractometry (D8
ADVANCE, Bruker AXS Inc, Madison, WI). A
monochromator features high flux K - a - 1 radiation at
40 kV and 100 mA was used. Diffractograms were per-
formed with 2h range from 0 to 40 with a step of 0.02, at
a scanning speed of 4/min (2h).
Analysis of polymer bulk microstructure using DSC
The structures of the polymer bulk, the melting point
temperature of polymers were characterized using a dif-
ferential scanning calorimetric (DSC) thermogram analyser
(STA 6000 Simultaneous Thermal Analyser, Perkin Elmer,
Waltham, MA). To perform the DSC analysis, 5 mg of
MePEG-PCL diblock copolymer samples was sealed sep-
arately in a standard aluminum pan, and purged with pure
dry nitrogen gas set at a flow rate of 10 ml/min, the tem-
perature variation was set at 10 C/min, and the heat flow
was recorded from 30 to 200 C.
Manufacture of MePEG-PCL diblock copolymer
films
The polymeric surface properties were investigated by
making thin film of MePEG-PCL diblock copolymers.
50 mg of polymers was dissolved in 1 ml of methylene
chloride and 100 ll of the solution was spin-cast on glass
slides to make uniform (*1 cm2 area) layer of film. The
films were allowed to dry under laminar air flow (Esco
laminar flow hood) for 2 h followed by at least 24-h drying
under vacuum at room temperature in a desiccator to
remove the residual solvent. Further, for complete removal
of organic solvent, the samples were kept for 24 h under
vacuum at 60 C.
Determination of polymer surface topography
with AFM
The surface characteristics of the MePEG-PCL diblock
copolymers film were investigated by atomic force micro-
scopy (AFM) (JPK nanowizard II, JPK instrument, Berlin,
Germany) mounted with Zeiss lens. The samples were
scanned by intermittent air contact mode using pyramidal
cantilevers with silicon probes having force constants of
0.2 Nm-1. The surface structure was observed and imaged
using JPK data processing software in contact mode with
frequency of 200–400 kHz and scan speed of 2 Hz. Under
the chosen conditions, the observed features were stable in
all four scanning directions as well as during multiple scans
and at varying scan sizes. Cantilevers and parameters were
proved for proper work by scanning the surface of a cover
slide. All the images represent topographic data which were
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obtained from z-range amplification scanner controlled by
the z-piezo extension scanner feedback loop at a gain of
0.25–0.1 arbitrary units. The raw data were reprocessed
with the JPK-SPM data processing software (version spm-
3.4.11?).
Hydrolytic degradation of polymer films
The uniform and thin films (20 9 20 mm) of block
copolymers were prepared by dissolving 20 mg of each
sample in solvent and spin-casting the polymer solution
followed by air drying. The hydrolytic degradation of the
MePEG-PCL block copolymers was carried out in a 1 N
NaOH solution at 37 C. The samples and solution were
incubated in a beaker and put in a water bath with gentle
shaking. The samples were collected at predetermined time
intervals, washed with distilled water and dried to a con-
stant weight in a vacuum oven at 60 C for weighing.
Attachment of protein to polymer surfaces
The immobilized bovine trypsin was used as model sub-
stance, and was quantified according to its enzymatic
reactivity (Puleo 1996; Tessmar et al. 2003). The MePEG-
PCL diblock copolymers films were used for coupling
reaction with trypsin in 0.05 m TRIS buffer (pH = 8.0).
Trypsin was finally immobilized from a concentrated
1 mg/ml solution in TRIS buffer. The polymer films were
incubated separately with 2 ml of this solution for 2 h. The
polymer films were washed three times with PBS buffer
(pH = 7.4 containing 0.05 % Tween 20) to remove
excessive physically adhered trypsin. To determine the
amount of immobilized protein, the polymer films were
incubated with 2 ml of a 0.4 mg/ml solution of BAEE in
TRIS buffer at 37 C in 12-well plate (Corning, USA).
After 2 h, the enzymatic reaction was stopped by adding
500 ml of a 0.02 mg/ml solution of soybean trypsin inhi-
bitor in double distilled water. The UV absorbance was
read at 253 nm using spectrophotometer (SPECORD 210,
Analytik jena, Germany). The trypsin activity of polymer
films was measured independently five times. Experimental
values calculated from the absorption of sample solutions
were corrected for UV absorption of BAEE blank solution.
Critical micelle concentration (CMC)
The CMC of the micelles was measured using the fluo-
rescence dye solubilization method. The hydrophobic flu-
orescent dye pyrene undergoes well-known changes in
response to microenvironment polarity, so it was used as
probe in a fluorescence spectrophotometer (LS55, Perkin
Elmer, Waltham, USA). A 0.6 mM of pyrene in acetone
solution was added to glass vial, 10 ll of this solution was
mixed with 1.0 ml of the MePEG-PCL diblock copolymer
aqueous solution with concentration ranging from
2.5 9 10-3 to 5.0 mg/ml and kept in an incubator over-
night for equilibration (Arimura et al. 2005; Li et al. 2010).
The excitation spectra were scanned from 250 to 360 nm at
a fixed emission wavelength of 390 nm with bandwidth
3 nm. A sharp increase in the ratio of intensity at 338 and
333 nm (I338/I333) excitation occurs at the CMC as the
pyrene preferentially partitioned into the hydrophobic
cores of the micelles. The ratios of I338/I333 were calculated
and plotted against the concentration logarithm of micelles;
the CMC was obtained from the intersection of the two
tangent plots (Lavasanifar et al. 2001; Winnik and Regis-
mond 1996).
Preparation of pyrene-loaded micelles and in vitro
release kinetics
Pyrene-loaded MePEG-PCL diblock copolymeric micelles
were prepared by phase-separation/dialysis method (Mo-
hanty et al. 2010). Briefly, 100 mg of MePEG-PCL diblock
copolymer (MePEG20-PCL80 or MePEG40-PCL60 or
MePEG60-PCL40 or MePEG80-PCL20) and 20 mg of
pyrene were dissolved in 10 ml DMF. To the above solu-
tion, 20 ml of water was added to induce micellization
under agitation. The aqueous solution was placed in a
dialysis bag (molecular weight cutoff: 12 kDa, average
diameter 21 mm and average flat width 35 mm, as sup-
plied, Sigma) and dialyzed against doubly distilled water
for 36 h under shielded light to remove DMF. The resulted
micelle solution containing pyrene was lyophilized for
24 h (-80 C and \10 mm mercury pressure, Freezone
6lt, Labconco Corp., MO) using 1 % sucrose as cryopro-
tectant so that the micelles can easily re-disperse, when
required for further in vitro and in vivo evaluations. The
obtained dry powder was stored in a desiccator at 4 C.
The entrapment efficiency of micelles was determined by
dissolving 10 mg of the lyophilized sample in 5 ml of
acetone, sonicated for 2 min in an ice bath (VC 505,
Vibracell Sonics, Newton, USA) and centrifuged at
13,800 rpm for 10 min at 25 C (Sigma 1–15 K, Osterode,
Germany) to get clear supernatant, which was then ana-
lyzed by fluorescence spectrophotometer (LS55, Perkin
Elmer, Waltham, USA) (Mohanty et al. 2010). The
entrapment efficiency of micelle was calculated according
to the following equation:
EE %w=w
  ¼ Weight of pyrene in micelle
Weight of pyrene added
 100
In vitro release kinetics of all the four different pyrene-
loaded micelles were carried out separately by dispersing
50 mg of the pyrene-loaded micelles in 100 ml of PBS
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(0.1 M, pH 7.4, containing 0.1 % v/v of Tween 80). Tween
80 was used to maintain the sink condition (Aso et al.
1994). The micelle suspension was kept in Orbit shaker
rotating at 150 rpm in 37 C under shielded light. At pre-
determined time intervals, 2.0 mL of the sample was
extracted and centrifuged at 13,800 rpm, 4 C for 10 min,
the supernatants were collected and measured by fluores-
cence spectrophotometer (LS55, Perkin Elmer, Waltham,
USA); all measurements were performed in triplicates.
After being measured, the supernatant and precipitant were
immediately poured back for further analysis (Zhou et al.
2003).
Results and discussion
Polymer synthesis and polymer structure
The synthesis of MePEG-PCL block copolymers was car-
ried out by ring-opening copolymerization mechanism in
presence of catalyst. The combination of MePEG and e-CL
by covalent bonding yields diblock copolymers with bulk
microstructure containing MePEG hydrophilic part isolated
from PCL hydrophobic part. The PCL hydrophobic domain
contributes for long in vivo degradation times. The MePEG
content varies in different formulation. The characteriza-
tion of the block copolymers with the 1H-NMR shows the
spectrum of MePEG which is significant for all synthesized
MePEG-PCL diblock copolymers. The signal at 3.64 and
4.06 ppm is representative for three chemically equivalent
hydrogen atoms of the methyl group at the end of the
MePEG block and e-methylene proton in PCL block in the
polymer chains, respectively (Fig. 1). The GPC analysis of
polymer shows molecular weight relative to the poly(-
styrene) standards used for the calibration of the system.
The polydispersity indices of the MePEG-PCL diblock
copolymers indicate a narrow molecular weight distribu-
tion for all polymers (Table 1). These indicate that no
transesterification and/or backbiting reactions occurred
during the copolymerization. The experimentally deter-
mined block length of the MePEG chains has some devi-
ation from the manufacturer declaration; however, the
discrepancy was less than 5 % and it confirms that poly-
mers can be synthesized consistently (Peter et al. 1997).
Analysis of polymer bulk microstructure
with WAXD
The wide-angle X-ray diffraction (WAXD) analysis of
MePEG polymer and MePEG-PCL diblock copolymers are
carried out. The diffractograms of MePEG show a sharp
diffraction maxima at 2h = 198, 238 and 288. It is well
known that the PCL homopolymer is easy to crystallize.
The diffraction patterns of the diblock copolymers show a
broadly distributed signal in the range of 2h = 108–258,
which are related to the peaks of both MePEG and PCL
block (Fig. 2). It demonstrated that the conjugation of
MePEG and PCL suppressed the crystallization of PCL to
desirable extent and both the polymer chains are mixed
well in molecular level. In the diffractogram of MePEG20-
PCL80, the diffraction decreases due to lower content of
MePEG (Detchprohm et al. 2001; Senda et al. 2002).
Moreover, the presence of the sharp diffraction maxima
and halo in the WAXD diffractograms of MePEG-PCL
block copolymers represents crystalline and amorphous
polymer parts, respectively.
Fig. 1 1H-NMR spectrum
(300 MHz) of MePEG60-
PCL40 in CDCl3
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Analysis of polymer bulk microstructure using DSC
The DSC analysis allowed the quantitative evaluation of
thermal properties of the polymers such as melting point.
The thermograms of MePEG included a single, symmet-
rical endotherm peak at 64 C. PCL has well-known semi-
crystalline polymer and thermograms of MePEG-PCL
diblock copolymers had endotherm peaks at 65, 63, 62 and
59 C for MePEG20-PCL80, MePEG40-PCL60,
MePEG60-PCL40 and MePEG80-PCL20, respectively.
The single endotherms in the thermograms are the result of
the melting of both the PCL and MePEG blocks (Fig. 3).
However, as the MePEG content within the copolymer
decreases, the endotherm peaks for the MePEG-PCL block
copolymers approach the peak of PCL homopolymer (Al-
len et al. 1999; Skoglund and Fransson 1996). The shift in
melting point to lower temperatures demonstrates that there
are interactions between both polymer chains, due to their
covalent attachment which limits the mobility of MePEG
and PCL chains. The chain lengths of MePEG and PCL
influence the size and distribution of the polymer chains,
thus determining the polymer bulk microstructure. The
difference in hydrophilic part will most likely result in
difference in water uptake which ultimately influences the
degradation rate of polymers and release of incorporated
drug (Aso et al. 1994; Rashkov et al. 1996; Youxin et al.
1994).
Determination of polymer surface topography
with AFM
The bulk microstructures of the MePEG-PCL block
copolymers also influence the surface properties. The AFM
analysis of MePEG, PCL and different MePEG-PCL block
copolymers was carried out to get the two-dimensional
plots and histogram of surface topographies (Fig. 4). The
microphase separation pattern of this material, which was
mostly pronounced in the phase image, was characterized
(Lucke et al. 2000; Xiong et al. 1995). The plots were
shown for different MePEG-PCL block copolymers with
varying MePEG content and for pure PCL. The images of
MePEG-PCL block copolymer films and histogram show
small elevations on their surface, however, smooth poly-
mer surface topography formed by increased MePEG
content (Lucke et al. 2000; Xiong et al. 1995). The phase
contrast was related to the fact that at room temperature,
PCL was in a glassy state while MePEG was in a rubber-
like state. Consequently, the brighter areas in the phase
image (corresponding higher areas in topographic image)
can be attributed to stiff lamellae of PCL. With increase in
MePEG content of the polymers, the smoothness of the
surface increases and the surface topology of MePEG had
smooth topology with uniform histogram.











MePEG100-PCL0 0 5000 5244 5873 1.12 100:0
MePEG20-PCL80 175 25,000 21,270 28,714 1.35 24:76
MePEG40-PCL60 65.75 12,500 12,213 16,853 1.38 42:58
MePEG60-PCL40 29.16 8333.3 7511 9313 1.24 65:35
MePEG80-PCL20 10.96 6250 5872 7927 1.35 82:18
All molecular weight data were rounded to the nearest 100
a Determined on the basis of Mn of polymer calculated in GPC experiments and polydispersity indices (PI = Mw/Mn)
b Calculated from MePEG (Mw = 5000)
c Determined by 1HNMR spectroscopy (CDCl3)
Fig. 2 WAXD spectra of a PEG, b MePEG20-PCL80, c MePEG40-
PCL60, d MePEG60-PCL40, e MePEG80-PCL20
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Hydrolytic degradation of polymer films
The hydrolytic degradation occurs more prominently in
amorphous substances as compared to crystalline sub-
stances. The higher degradation rate in the amorphous
region is attributed to the easy diffusion of water molecules
into the interior of polymers. Figure 5 shows the weight
loss of polymer samples during hydrolytic degradation.
The degradation rate of block copolymers was slower than
those of MePEG depending on the crystallinity of the block
copolymers (Cho et al. 2001). The results show that the
hydrolytic degradation takes place preferentially in the
amorphous region rather than in the crystalline region
(Tsuji and Ikada 1997).
Determination of protein attachment to polymer
surfaces
The polymer surface biocompatibility and ability to form
covalent bond with proteins and peptides was investigated
by taking trypsin as a model protein. Different polymers
(MePEG-PCL block copolymers, MePEG and PCL) and
the non-coated glass slides were studied and enzymatic
activity was calculated (Fig. 6). All the experiments were
performed three times and the average enzymatic activity
was calculated (Puleo 1996; Tessmar et al. 2003). The UV
absorption measures showed that MePEG20-PCL80 block
copolymer films had higher absorption than other polymer
films, due to presence of MePEG on the polymer surface
(Andrade et al. 1992; Bazile et al. 1995; Stolnik et al.
1994). The sensitivity of UV-spectroscopic method was
illustrated by small standard deviations when Na-benzoyl-
L-arginine (BA) was cleaved from Na-benzoyl-l-arginine
ethylester (BAEE). The UV absorbance for glass and PCL
that served as negative controls was relatively high, due to
adsorption of protein on the bottom of the glass slides. The
increases in UV absorption show the ability of MePEG-
PCL block copolymers to covalently bind with immobilize
trypsin (Puleo 1996; Tessmar et al. 2003). However, the
results verify that the four block copolymers have different
adsorption properties depending on the MePEG chains, and
it was suited to bind bioactive substances in solid phase
(Lucke et al. 2000). The MePEG polymer surface mini-
mizes the unspecific cell adhesion of polymer, and in the
same time it helps in functionalization of polymer surface
by covalent bonding of targeting moieties that mediate the
selective target to specific tissues/cells by the enhanced
permeability and retention (EPR) effect. The control of
peptide and protein adsorption on the surface of polymer is
essential to control cell function.
Critical micelle concentration (CMC)
The CMC value of block copolymer indicates the stability
of micellar formulation upon dilution in body fluids fol-
lowed by intravenous administration. The formation of the
Fig. 3 Thermograms obtained by DSC measurements for determination of the crystallinity of the polymers a MePEG, b MePEG20-PCL80,
c MePEG40-PCL60, d MePEG60-PCL40, e MePEG80-PCL20, f PCL
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Fig. 4 Surface topography of polymer films by AFM studies a PCL, b MePEG20-PCL80, c MePEG40-PCL60, d MePEG60-PCL40,
e MePEG80-PCL20, f MePEG
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micelles was evaluated by CMC measurement using pyr-
ene as a florescent probe. Pyrene was preferentially parti-
tioned into the hydrophobic domain of the micelles and to
make change in polarity or photophysical properties of the
solution. The excitation spectra of pyrene shift from 333 to
338 nm. The ratio of pyrene fluorescence intensities at 338
and 333 nm (I338/I333) was plotted as a function of loga-
rithm of block copolymer concentration of all polymers.
The CMC value of MePEG80-PCL20 (8.2 9 10-3 mg/ml)
was higher than the CMC value of MePEG60-PCL40
(5.9 9 10-3 mg/ml), MePEG40-PCL60 (4.8 9 10-3 mg/
ml) and MePEG20-PCL80 (3.9 9 10-3 mg/ml). The
intensity ratio remained almost unchanged at low copoly-
mer concentrations and increased abruptly once the
copolymer concentration reached the CMC, indicating the
formation of micelles (Kabanov et al. 1995; Piao et al.
2003). The CMC value depends on the hydrophilic–lipo-
philic balance (HLB) of block copolymers, and increases
with increase in the hydrophilic block lengths, leading to
instability of micelles (Xiong et al. 1995; Yokoyama
2010). The lower CMC of MePEG20-PCL80 and
MePEG40-PCL60 indicated their higher thermodynamic
stability, representing an advantage upon injection into
body fluids. This was due to incorporation of PCL units to
the block copolymer chain (Fig. 7).
Preparation of pyrene-loaded micelles and in vitro
release kinetics
The pyrene was successfully loaded in the different
MePEG-PCL block copolymeric micelles by modified
dialysis method. The entrapment efficiency of different
micellar formulation was an important factor for deter-
mining the release profile of drug delivery system. The
entrapment efficiency of pyrene in different formulation
was determined by fluorescence spectrophotometer and
found to be *57.2 % (MePEG80-PCL20), *63.1 %
(MePEG60-PCL40), *67.4 % (MePEG40-PCL60) and
*70.1 % (MePEG20-PCL80). The higher molecular
weight and presence of large hydrophobic chain length of
block copolymer results in high entrapment of pyrene (Shin
et al. 1998; Yokoyama 2010). The release profile of pyrene
from the different MePEG-PCL micelles was carried out
in vitro physiological body fluid condition (PBS 0.01 M,
pH = 7.4, 0.1 % v/v Tween 80) for 48 h. The release of
pyrene shows a typical biphasic pattern, indicating the first
Fig. 5 The weight loss of block copolymers as a function of
hydrolysis time in the 1 N NaOH solution
Fig. 6 Binding of trypsin to
different surfaces, determined
by BAEE assay (UV detection
k = 253 nm)
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burst release due to rapid diffusion of pyrene from poly-
meric matrix and later phase release was mediated by
degradation of the polymeric matrix (Fig. 8). In case of
MePEG80-PCL20 and MePEG60-PCL40 micellar formu-
lation, pyrene release was found to be 61 ± 1.3 % and
59 ± 1.6 %, respectively, in the first instance, followed by
slow and continuous release. Similarly, in case of
MePEG40-PCL60 and MePEG20-PCL80 micellar formu-
lations, the release was 56 ± 1.4 and 51 ± 1.2 %,
respectively, in the first instance followed by sustained
release (Ma et al. 2008). It was reported that as loading of
the drug in micelle increases, the release rate decreases
(Kim et al. 2004; Shin et al. 1998). The higher entrapment
efficiency of MePEG20-PCL80 micellar formulation
increases the hydrophobic properties of pyrene in core,
favors enhanced interaction between pyrene and core of
micelle, leading to decreased drug release (Uhrich et al.
1999).
Conclusions
A series of MePEG-PCL biodegradable block copolymers
were synthesized and explored its application for drug
delivery. The results obtained show that the bonding of
various compositions of hydrophobic PCL and hydrophilic
MePEG leads to the desired effect on polymer bulk
microstructure, surface properties and hydrolytic degrada-
tion. The variation of polymer composition regulates the
ability of binding of model substances, such as proteins in
solution or in solid phase. The CMC of the block copoly-
mer shows the micelle-forming ability of the MePEG-PCL
block copolymers to encapsulate hydrophobic drug. The
in vitro release kinetic studies showed that the release of
encapsulated hydrophobic substance has initial burst
release followed by sustained release. Theses specifically
designed MePEG-PCL block copolymer may be further
explored as vehicle for controlled drug delivery by esca-
lating EPR effect. The modification on polymer properties
can aid in the development of customized release profiles.
These copolymers can also be further modified as biomi-
metic copolymers by exploiting covalently bonded growth
Fig. 7 Plots of intensity ratio
(I338/I333) of the excitation
spectra of pyrene against log C
of block copolymers
Fig. 8 In vitro release kinetics of pyrene from different formulation
of MePEG-PCL copolymeric micelles in PBS (0.01 M, pH 7.4) at
37 C. (Data as mean ± standard error of mean, n = 3)
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factors and cell adhesion peptides, which can be used for
controlled tissue engineering.
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